rs1060501346
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_001048174.2(MUTYH):c.638G>A(p.Arg213Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000157 in 1,461,764 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R213W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001048174.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUTYH | ENST00000456914.7 | c.638G>A | p.Arg213Gln | missense_variant | 9/16 | 1 | NM_001048174.2 | ENSP00000407590.2 | ||
ENSG00000288208 | ENST00000671898.1 | n.1226G>A | non_coding_transcript_exon_variant | 13/21 | ENSP00000499896.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250422Hom.: 1 AF XY: 0.0000442 AC XY: 6AN XY: 135622
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461764Hom.: 1 Cov.: 36 AF XY: 0.0000289 AC XY: 21AN XY: 727180
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 2 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 241 of the MUTYH protein (p.Arg241Gln). This variant is present in population databases (no rsID available, gnomAD 0.02%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individuals with polyposis or colon cancer and polyposis (100-500 polyps) and colorectal cancer (PMID: 19732775, 21520333; Invitae). ClinVar contains an entry for this variant (Variation ID: 406867). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Arg241 amino acid residue in MUTYH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14991577, 15673720, 24470512, 25820570, 27194394; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 12, 2023 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 08, 2024 | The p.R241Q variant (also known as c.722G>A), located in coding exon 9 of the MUTYH gene, results from a G to A substitution at nucleotide position 722. The arginine at codon 241 is replaced by glutamine, an amino acid with highly similar properties. This alteration has been reported in conjunction with a pathogenic MUTYH mutation in an individual diagnosed with colorectal cancer and polyposis (45y, 100-550 colorectal polyps), breast cancer (60y, 68y), spinalioma (68y), as well as a benign skin tumor, from a cohort of 276 index patients with adenomatous polyposis (Vogt S et al. Gastroenterology. 2009 Dec;137:1976-85.e1-10). This alteration has also been reported in 1 of 257 patients with MUTYH-associated polyposis (MAP) (Nielsen M et al. Gastroenterology. 2009 Feb;136:471-6). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jan 31, 2022 | This missense variant replaces arginine with glutamine at codon 241 of the MUTYH protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant, however, studies have shown that a different missense substitution at the same codon (p.Arg241Trp, also known as p.Arg227Trp in the literature) affects DNA binding and glycosylase activity of the MUTYH protein (PMID: 15673720, 25820570). The variant c.722G>A has been reported with a pathogenic variant (p.Gly396Asp) in MUTYH in an individual with polyposis (100-500 polyps), colorectal cancer, breast cancer, and spinalioma (PMID: 19732775). While it is unknown if these two variants are on the same or opposite chromosomes, this observation suggests the c.722G>A substitution may contribute to the cause of disease. Also, this variant has been observed in homozygosity in an individual with polyposis (PMID: 21520333). This variant has been identified in 7/250422 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at